TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19697824

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1 microg kg(‐1) over 10 min, followed by 0.2 microg kg(‐1) h(‐1) continuous infusion)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 16537185

Group type: EXPERIMENTAL
Intervention: Single epirubicin (80 mg/40 mL of normal saline) administered into the bladder within 6 hours postoperation
Number of subjects: 47

Group type: COMPARATOR
Intervention: 40 mg Epirubicin consecutively, instillation every week for 6-8 weeks and then every one month for 10 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: 40 mg mitomycin C, consecutively, instillation every week for 6-8 weeks and then every one month for 10 months
Number of subjects: 47
Study: 16167266

Group type: EXPERIMENTAL
Intervention: Postoperative brace set at full extension (group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Postoperative brace set at flexion of 20 degrees (group B)
Number of subjects: 46
Study: 12962937

Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 102

Group type: COMPARATOR
Intervention: Vaginal metronidazole
Number of subjects: 102
Study: 10436093

Group type: EXPERIMENTAL
Intervention: Caregiver Strain Index measurement at 1, 3, and 6 months after stroke
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke severity indicator
Number of subjects: 0
Study: 8526836

Group type: EXPERIMENTAL
Intervention: Countermeasures (CM) including regular muscular exercise and LBNP sessions (‐30 mm Hg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Countermeasures (CM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (CM and C)
Number of subjects: 12
Study: 2487539

Group type: EXPERIMENTAL
Intervention: tiapamil 450 mg b.i.d.
Number of subjects: 81

Group type: COMPARATOR
Intervention: atenolol 100 mg daily
Number of subjects: 81
Study: 322529

Group type: EXPERIMENTAL
Intervention: 10 g of vitamin C
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 31404668

Group type: EXPERIMENTAL
Intervention: Reslizumab 3.0 mg/kg
Number of subjects: 1758

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1758
Study: 28450898

Group type: EXPERIMENTAL
Intervention: Foot orthoses and prescribed motion control shoes
Number of subjects: 44

Group type: COMPARATOR
Intervention: Prescribed motion control shoes alone
Number of subjects: 44
Study: 25974287

Group type: EXPERIMENTAL
Intervention: Amitriptyline (titrated to a median of 50 mg, interquartile range 25-50 mg)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 27053951

Group type: EXPERIMENTAL
Intervention: TS audiometer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional audiometer
Number of subjects: 60
Study: 21845239

Group type: EXPERIMENTAL
Intervention: Sandblasting
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tribochemical silica coating
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tribochemical silica coating + silanization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 19234425

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (10 sessions over 5 weeks)
Number of subjects: 8
Study: 16317318

Group type: EXPERIMENTAL
Intervention: Visual-feedback therapy (bimonthly sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Supportive counselling (control group)
Number of subjects: 30
Study: 12725603

Group type: EXPERIMENTAL
Intervention: Triple therapy with omeprazole, clarithromycin, and tinidazole for 7 days followed by omeprazole for 21 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: Triple therapy with omeprazole, clarithromycin, and tinidazole for 7 days followed by placebo for 21 days
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups (after 16 weeks)
Number of subjects: 103
Study: 10950759

Group type: EXPERIMENTAL
Intervention: Group C rotavirus infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group C rotavirus strains
Number of subjects: 0
Study: 9165933

Group type: EXPERIMENTAL
Intervention: Tactile only (T)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Auditory, tactile and visual (ATV)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual and vestibular (ATVV)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Auditory only (A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 54
Study: 8259721

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ) 200 mg daily and placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) and Methotrexate (MTX) 7.5 mg once a week
Number of subjects: 40
Study: 3916621

Group type: EXPERIMENTAL
Intervention: Computer assisted conventional insulin therapy
Number of subjects: 17
Study: 29807740

Group type: EXPERIMENTAL
Intervention: Correlation method
Number of subjects: 21

Group type: COMPARATOR
Intervention: Library method
Number of subjects: 21
Study: 28228182

Group type: EXPERIMENTAL
Intervention: MoodGYM (free-to-use cCBT programme)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beating the Blues (commercial cCBT programme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual GP care alone
Number of subjects: 0
Study: 26175297

Group type: EXPERIMENTAL
Intervention: Educational intervention (four sessions with one week interval)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine program offered by the center (control group)
Number of subjects: 90
Study: 23441790

Group type: EXPERIMENTAL
Intervention: 0.5% azithromycin (AZM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 54
Study: 21995887

Group type: EXPERIMENTAL
Intervention: Postdischarge formula (PDF; n=52, 0.4% DHA, 0.4% AA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Term formula (TF; n=41, 0.2% DHA, 0.2% AA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Human milk (HM; n=46)
Number of subjects: 139
Study: 18164104

Group type: EXPERIMENTAL
Intervention: Scenario-based simulation training
Number of subjects: 141

Group type: COMPARATOR
Intervention: Scenario-based study groups with teacher
Number of subjects: 141

Group type: COMPARATOR
Intervention: Scenario-based study groups without teacher
Number of subjects: 141
Study: 16829083

Group type: EXPERIMENTAL
Intervention: On-CPB with cell saver blood transfusion (CSBT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: On-CPB without CSBT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Off-pump with CSBT
Number of subjects: 80

Group type: COMPARATOR
Intervention: Off-pump without CSBT
Number of subjects: 80

Group type: COMPARATOR
Intervention: On-CPB (both with and without CSBT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cell saver groups (A and C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 12949925

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavior therapy
Number of subjects: 125
Study: 11729513

Group type: EXPERIMENTAL
Intervention: TPN + FDP (1 g/kg daily for dogs; 5 g, two times a day for patients)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: TPN + FDP
Number of subjects: 29

Group type: COMPARATOR
Intervention: Routine TPN (control group for clinical study)
Number of subjects: 29
Study: 9605271

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 884

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 884
Study: 8156344

Group type: EXPERIMENTAL
Intervention: Radical systematic lymphadenectomy
Number of subjects: 182

Group type: COMPARATOR
Intervention: Conventional node dissection
Number of subjects: 182
Study: 3419826

Group type: EXPERIMENTAL
Intervention: cyclopentolate HCl 1%
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: phenylephrine HCl 10%
Number of subjects: 10

Group type: COMPARATOR
Intervention: saline 0.9%
Number of subjects: 10
Study: 31644793

Group type: EXPERIMENTAL
Intervention: Smartphone app care (IBDsmart and IBDoc)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard face-to-face care
Number of subjects: 100
Study: 31079530

Group type: EXPERIMENTAL
Intervention: Sodium reduction (9 slow sodium tablets daily for 6 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (placebo tablets daily for 6 weeks)
Number of subjects: 64
Study: 28248624

Group type: EXPERIMENTAL
Intervention: Interactive website intervention
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 26387142

Group type: EXPERIMENTAL
Intervention: THP (docetaxel with trastuzumab and pertuzumab)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: TH/TP/HP (docetaxel with trastuzumab, pertuzumab, or both)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Trastuzumab/chemotherapy (from NOAH trial)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Chemotherapy only (from NOAH trial)
Number of subjects: 350
Study: 23942540

Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM) plus AED strong inducers (carbamazepine, phenobarbital, phenytoin), n = 33
Number of subjects: 75
Study: 21673612

Group type: EXPERIMENTAL
Intervention: Plain polysaccharide vaccine (MenC-PS group, n=150)
Number of subjects: 543

Group type: EXPERIMENTAL
Intervention: Glycoconjugate vaccine (MenC-CRM group, n=95)
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group (n=298)
Number of subjects: 543
Study: 18325740

Group type: EXPERIMENTAL
Intervention: Galantamine (32 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16571761

Group type: EXPERIMENTAL
Intervention: Attention-related activity for large-scale targets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention-related activity for small-scale targets
Number of subjects: 0
Study: 12628548

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR-1 and L. fermentum RC-14
Number of subjects: 64
Study: 10234640

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fixed plaster cast stretching
Number of subjects: 20
Study: 8920846

Group type: EXPERIMENTAL
Intervention: Different manipulations of rod length in Experiment 1
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Wielding rods of two ranges (long and short) in Experiment 2
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Handling dense or light rods in Experiment 3
Number of subjects: 49
Study: 1776539

Group type: EXPERIMENTAL
Intervention: sight and smell of the alcoholic beverage most commonly consumed by each subject
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: sight and smell of preferred drink (20 presentations)
Number of subjects: 16
Study: 7108667

Group type: EXPERIMENTAL
Intervention: Indomethacin followed immediately by furosemide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Indomethacin alone
Number of subjects: 19
Study: 31077873

Group type: EXPERIMENTAL
Intervention: KCNB2 rs349358 SNP
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Genetic risk score based on CHRM3 rs2165870 and KCNB2 rs349358 SNP
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Apfel Score
Number of subjects: 472
Study: 31647774

Group type: EXPERIMENTAL
Intervention: NIR t‐PBM (n=9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: NIR t‐PBM (n=6)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham (n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham (n=8)
Number of subjects: 18
Study: 28923758

Group type: EXPERIMENTAL
Intervention: Solo vibrating mesh nebulizer
Number of subjects: 15

Group type: COMPARATOR
Intervention: Wright jet nebulizer
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both nebulizers
Number of subjects: 15
Study: 26825276

Group type: EXPERIMENTAL
Intervention: Referral for care during the early neonatal period (ENP: 0-7 days old)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral for care during the late neonatal period (LNP: 8-28 days old)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral reasons for boys during the ENP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral reasons for girls during the ENP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral reasons for boys during the LNP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Referral reasons for girls during the LNP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care-seeking behavior for referred neonates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Impact of family composition on care-seeking behavior
Number of subjects: 0
Study: 23301548

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) or emtricitabine (FTC)/TDF therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Wild-type HBV
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: TDF or FTC/TDF therapy
Number of subjects: 105
Study: 21973194

Group type: EXPERIMENTAL
Intervention: 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel
Number of subjects: 16

Group type: COMPARATOR
Intervention: 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser monotherapy
Number of subjects: 16
Study: 17681325

Group type: EXPERIMENTAL
Intervention: Highly purified hMG
Number of subjects: 629

Group type: COMPARATOR
Intervention: Recombinant FSH (rFSH)
Number of subjects: 629
Study: 16505078

Group type: COMPARATOR
Intervention: R&S only (n = 315)
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: R&S + AaR (n = 284)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Usual care (control group, n = 603)
Number of subjects: 1202
Study: 15349912

Group type: EXPERIMENTAL
Intervention: Telbivudine 800 mg/d
Number of subjects: 43

Group type: COMPARATOR
Intervention: Telbivudine (various doses: 25, 50, 100, 200, 400, and 800 mg/d)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Telbivudine (400 mg/d or more)
Number of subjects: 43
Study: 10759446

Group type: EXPERIMENTAL
Intervention: Supervised training on a treadmill, 4 days/week (group S; n=21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Self-monitored walking 3 or 4 km in 1 hour, 4 days/week (group SM; n=20)
Number of subjects: 41
Study: 8839087

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.25 mg.kg-1 intravenously (two doses)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg.kg-1 intravenously (two doses)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1495854

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with continued surfactant therapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Exogenous surfactant therapy
Number of subjects: 28
Study: 6379678

Group type: EXPERIMENTAL
Intervention: 200 mg indoprofen 4-times daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: 25 mg indomethacin 4-times daily
Number of subjects: 19
Study: 3527306

Group type: COMPARATOR
Intervention: Tamoxifen (T)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus aminoglutethimide and hydrocortisone (T+AG+H)
Number of subjects: 210
Study: 29402368

Group type: EXPERIMENTAL
Intervention: Humulin group
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low-intensity group
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: High-intensity group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 72
Study: 27115752

Group type: EXPERIMENTAL
Intervention: Novel instrument used during operation in the experimental group
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no novel instrument used)
Number of subjects: 68
Study: 24856792

Group type: EXPERIMENTAL
Intervention: Static stretching intervention for six weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study: 22362927

Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD)
Number of subjects: 3416

Group type: COMPARATOR
Intervention: No periodontal disease (PD)
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD) in non-Caucasian women
Number of subjects: 3416

Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD) in Caucasian women
Number of subjects: 3416
Study: 20197607

Group type: EXPERIMENTAL
Intervention: Ulinastatin (1.5 x 10^4 U/kg before CPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 18454224

Group type: EXPERIMENTAL
Intervention: Zinc sulfate 150 mg twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dapsone 50 mg twice daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Glucose 250 mg as placebo
Number of subjects: 45
Study: 16170707

Group type: EXPERIMENTAL
Intervention: Intraarterial lipiodol application in Group A
Number of subjects: 36

Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE) in Group B
Number of subjects: 36
Study: 14758431

Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Paternal education
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Miscarriage in previous pregnancy
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Prior child deaths
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Larger maternal mid-upper arm circumference
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: No tetanus vaccinations during pregnancy
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Severe illness during third trimester
Number of subjects: 15469

Group type: EXPERIMENTAL
Intervention: Maternal mortality
Number of subjects: 15469
Study: 18425652

Group type: EXPERIMENTAL
Intervention: Calorie restriction (1000-1200 kcal/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Dietary fat restriction (22-26 g/day)
Number of subjects: 80
Study: 9198425

Group type: EXPERIMENTAL
Intervention: Cavit
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Intermediate Restorative Material (IRM)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: TERM
Number of subjects: 51
Study: 1753937

Group type: EXPERIMENTAL
Intervention: Local and systemic treatment with salcatonin
Number of subjects: 0
Study: 6643769

Group type: EXPERIMENTAL
Intervention: UVB monitor (sensitive to 300 nm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UVA monitor (sensitive to 355 nm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunlight exposure for rezeroing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunlight-calibrated UVB monitor
Number of subjects: 0
Study: 30676141

Group type: EXPERIMENTAL
Intervention: Self-Selected (SS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 3 minute (3MIN)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 5 minute (5MIN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 3MIN, 5MIN, SS
Number of subjects: 16
Study: 30815106

Group type: EXPERIMENTAL
Intervention: Algorithmic import of potentially missing child concepts evaluated by a human expert.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human expert evaluation of child concepts.
Number of subjects: 0
Study: 25950773

Group type: EXPERIMENTAL
Intervention: Health knowledge training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 22
Study: 25322881

Group type: EXPERIMENTAL
Intervention: Education + Monitoring (n = 87)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Education Control (n = 50)
Number of subjects: 137
Study: 22435320

Group type: EXPERIMENTAL
Intervention: Waterpik Water Flosser (WF) plus manual tooth brushing
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sonicare Air Floss (AF) plus manual tooth brushing
Number of subjects: 82
Study: 20448327

Group type: EXPERIMENTAL
Intervention: Flextend Orthotic Exercise glove group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 17580516

Group type: EXPERIMENTAL
Intervention: Colchicine as adjunct to conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study: 16145640

Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg added to 40 ml prilocaine 1.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clonidine 1.5 microg/kg added to 40 ml prilocaine 1.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prilocaine 1.5% without additional medication (Control)
Number of subjects: 60
Study: 11835111

Group type: EXPERIMENTAL
Intervention: Sodium profile (decreasing sodium concentration from 145 to 133 mmol/L)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Constant sodium concentration (138 mmol/L)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sodium profile (decreasing sodium concentration)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Constant sodium concentration
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both sodium profile and constant sodium concentration
Number of subjects: 9
Study: 8982181

Group type: EXPERIMENTAL
Intervention: Perpendicular incisions to hair follicles
Number of subjects: 30

Group type: COMPARATOR
Intervention: Parallel incisions to hair follicles
Number of subjects: 30
Study: 8194628

Group type: EXPERIMENTAL
Intervention: Captopril therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3307991

Group type: EXPERIMENTAL
Intervention: Medial incision of the anterior rectus sheath
Number of subjects: 360

Group type: COMPARATOR
Intervention: Group A (standard lateral paramedian incision)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Group B (anterior sheath incised medially, posterior sheath incised laterally)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Group C (anterior sheath incised laterally, posterior sheath incised medially)
Number of subjects: 360
Study: 31941445

Group type: EXPERIMENTAL
Intervention: Using social media to seek sexual partners
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: HIV self-testing
Number of subjects: 2006

Group type: EXPERIMENTAL
Intervention: Disclosing sexual orientation to a healthcare provider
Number of subjects: 2006
Study: 31626156

Group type: EXPERIMENTAL
Intervention: Standard therapy + VR (15 minutes twice daily for 10 days)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 78
Study: 28629351

Group type: EXPERIMENTAL
Intervention: HRQOL assessment considered important in daily work
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: HRQOL assessment practices
Number of subjects: 1557

Group type: EXPERIMENTAL
Intervention: HRQOL assessment barriers
Number of subjects: 1557
Study: 26289403

Group type: EXPERIMENTAL
Intervention: Mobile Phone Resuscitation Guide (MPRG)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No MPRG (Control)
Number of subjects: 21